179 related articles for article (PubMed ID: 33875971)
1. Neurological manifestations of patients with mild-to-moderate COVID-19 attending a public hospital in Lima, Peru.
Carcamo Garcia MH; Garcia Choza DD; Salazar Linares BJ; Diaz MM
eNeurologicalSci; 2021 Jun; 23():100338. PubMed ID: 33875971
[TBL] [Abstract][Full Text] [Related]
2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
[TBL] [Abstract][Full Text] [Related]
3. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
4. Neurological Manifestations in Hospitalized Geriatric Patients With COVID-19 at King Abdulaziz Medical City in Jeddah, Western Region, Saudi Arabia From 2020 to 2021: A Cross-Sectional Study.
Marghalani YO; Kaneetah AH; Khan MA; Albakistani AA; Alzahrani SG; Kidwai A; Alansari KW; Alhamid HS; Alharbi MH; Attar A
Cureus; 2023 Sep; 15(9):e45759. PubMed ID: 37876390
[TBL] [Abstract][Full Text] [Related]
5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
6. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
7. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
[TBL] [Abstract][Full Text] [Related]
8. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study.
Amanat M; Rezaei N; Roozbeh M; Shojaei M; Tafakhori A; Zoghi A; Darazam IA; Salehi M; Karimialavijeh E; Lima BS; Garakani A; Vaccaro A; Ramezani M
BMC Neurol; 2021 Mar; 21(1):116. PubMed ID: 33726699
[TBL] [Abstract][Full Text] [Related]
9. [Cross-sectional study of the clinical characteristics and outcomes of children hospitalized with COVID-19 in Lima, Peru].
Domínguez Rojas J; Estupiñan Vigil M; Garcés-Ghilardi R; Alvarado-Gamarra G; Del Águila O; Lope Tenorio AF; Ayón Dejo CC; Chonlon Murillo K; Boluarte Baca S; Stapleton Herbozo A; Seminario Aliaga R; Reyes Florian G; Dávila Riega D; Fernández Suárez S; Coronado Muñoz Á
Medwave; 2021 Jan; 21(1):e8107. PubMed ID: 33617519
[TBL] [Abstract][Full Text] [Related]
10. Subacute neurological sequelae in mild COVID-19 outpatients.
Taskiran-Sag A; Eroğlu E; Canlar Ş; Poyraz BM; Özülken K; Mumcuoğlu T; Numanoğlu N
Tuberk Toraks; 2022 Mar; 70(1):27-36. PubMed ID: 35362302
[TBL] [Abstract][Full Text] [Related]
11. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection.
Özçelik Korkmaz M; Eğilmez OK; Özçelik MA; Güven M
Eur Arch Otorhinolaryngol; 2021 May; 278(5):1675-1685. PubMed ID: 33011957
[TBL] [Abstract][Full Text] [Related]
12. Neurological and Psychiatric Manifestations of Post-COVID-19 Conditions.
Jung YH; Ha EH; Park J; Choe KW; Lee WJ; Jo DH
J Korean Med Sci; 2023 Mar; 38(11):e83. PubMed ID: 36942392
[TBL] [Abstract][Full Text] [Related]
13. Neurological symptoms of COVID-19 infection; a cross-sectional study on hospitalized COVID-19 patients in Iran.
Nejad JH; Allahyari F; Hosseinzadeh R; Heiat M; Ranjbar R
Clin Neurol Neurosurg; 2021 Nov; 210():106985. PubMed ID: 34700274
[TBL] [Abstract][Full Text] [Related]
14. Neurological symptoms and comorbidity profile of hospitalized patients with COVID-19.
Cremaschi RC; Bahi CAS; Paola AAV; Arakaki JSO; Ferreira PRA; Bellei NCJ; Borges V; Coelho FMS
Arq Neuropsiquiatr; 2023 Feb; 81(2):146-154. PubMed ID: 36948200
[TBL] [Abstract][Full Text] [Related]
15. Neurological features and outcome in COVID-19: dementia can predict severe disease.
Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS
J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193
[TBL] [Abstract][Full Text] [Related]
16. Loss of Taste and Smell are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study.
Farah Yusuf Mohamud M; Garad Mohamed Y; Mohamed Ali A; Ali Adam B
Infect Drug Resist; 2020; 13():2631-2635. PubMed ID: 32801800
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
[TBL] [Abstract][Full Text] [Related]
18. Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort.
Marcolino MS; Anschau F; Kopittke L; Pires MC; Barbosa IG; Pereira DN; Ramos LEF; Assunção LFI; Costa ASM; Nogueira MCA; Duani H; Martins KPMP; Moreira LB; Silva CTCAD; Oliveira NR; Ziegelmann PK; Guimarães-Júnior MH; Lima MOSS; Aguiar RLO; Menezes LSM; Oliveira TF; Souza MD; Farace BL; Cimini CCR; Maurílio AO; Guimarães SMM; Araújo SF; Nascimento GF; Silveira DV; Ruschel KB; Oliveira TC; Schwarzbold AV; Nasi LA; Floriani MA; Santos VBD; Ramos CM; Alvarenga JC; Scotton ALBA; Manenti ERF; Crestani GP; Batista JDL; Ponce D; Machado-Rugolo J; Bezerra AFB; Martelli PJL; Vianna HR; Castro LC; Medeiros CRG; Vietta GG; Pereira EC; Chatkin JM; Godoy MF; Delfino-Pereira P; Teixeira AL
J Neurol Sci; 2022 Dec; 443():120485. PubMed ID: 36375382
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Ear, Nose and Throat Manifestations in COVID-19 Patients.
El-Anwar MW; Eesa M; Mansour W; Zake LG; Hendawy E
Int Arch Otorhinolaryngol; 2021 Jul; 25(3):e343-e348. PubMed ID: 34377166
[No Abstract] [Full Text] [Related]
20. Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.
Al-Shouli ST; Meo SA; Alafaleq NO; Sumaily KM; Alshehri A; Almutairi A; Eidalsharif A; Alsulami F; Alhanaya S
Viruses; 2023 May; 15(6):. PubMed ID: 37376577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
